Southeast Regional Biotechs Get Chance to Connect with Investors and Potential Partners
At the end of March, RESI South 2024 will convene in Atlanta and is expected to bring together more than 500 bioscience and medtech entrepreneurs with premier investors, family offices, and key executives. The event, the result of a partnership between Life Science Nation and the Southeast Life Sciences, will highlight the innovative start-ups in […]
Podcast: Ocean Biomedical Seeks to Capitalize on a Wave of Academic Innovation
Universities around the world are driving scientific advances that could provide needed new medicines, but despite the billions of dollars that fuel this research every year, academic researchers lack the capital and expertise to perform the necessary translational science to advance promising therapies out of the lab and into the clinic. Ocean Biomedical se
Podcast: The Art of Raising Money for a Life Sciences Company
BioStartup News · The Art of Raising Money for a Life Sciences Company Some of the biggest challenges executives of early-stage life sciences companies face is securing financing and forging their first licensing deals. Though they may possess deep scientific knowledge, finding the right investors and partners, and telling their story in a compelling way [&
Things to Think About When Starting a Life Sciences/Healthcare Company
SEED SHOWCASE 2023 RECAP By Marie Daghlian Three themes to think about as you go about starting a company—the state of the market and raising capital, alignment, and geography—were covered at a well-attended and wide-ranging panel discussion at the first Seed Showcase during the J.P. Morgan Healthcare Conference week, recently held in San Francisco. Entr
Building a Forever Biotech in This Market
This post was originally published by Halloran Consulting Group. Building a biotech company is not for the faint of heart. It requires scientific expertise, business and organizational focus, and advanced knowledge of product development and commercialization to harness to formulate the company and secure fundraising to sustain growth. No one found
Coverage of the Start-up Stadium at BIO 2022 (Part 2)
Part 1 of Big4Bio’s coverage of the Start-up Stadium at BIO 2022 covered the criteria and process for all of the participating companies, and now Bernard Fallon, Managing Director, Industry Research, Investor Outreach, and Education at BIO reached out to us since the conference with an update: In addition to a complementary one-year BIO membership, a
Coverage of the Start-up Stadium at BIO 2022 (Part 1)
Forty-four early and seed stage companies are presenting at this year’s Start-up Stadium held during the BIO 2022 Conference in San Diego. These companies were selected to present live during the conference from among the more than 150 companies that submitted applications including their pitch decks in April. The applications were revi
Our first podcast! Navigating the Changing Landscape for the Bioentrepreneur
Johannes Fruehauf has great visibility into the changing landscape for life sciences startups as a seasoned entrepreneur, a venture investor, and co-founder and president of the biotech startup co-working space BioLabs. While the public market downturn has changed the financing environment, it hasn’t slowed the pace of entrepreneurs looking to translate br